Deuterated compounds and uses thereof
AssigneeBiostatus Limited
InventorsStefan OGRODZINSKI, Paul SMITH, Stephanie MCKEOWN, Laurence PATTERSON, Rachel Jane ERRINGTON
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiostatus Limited
InventorsStefan OGRODZINSKI, Paul SMITH, Stephanie MCKEOWN, Laurence PATTERSON, Rachel Jane ERRINGTON
Estimating the term…
An anthraquinone compound of formula I (such as the compounds of formulae II to X) and processes for making the same are provided. Pharmaceutical compositions for use in the treatment of cancer, optionally in combination with an agent capable of reducing the level of oxygenation of a tumour, are also provided. Additionally, an option for combination with chemotherapeutic and radiotherapeutic modalities to enhance overall tumour cell kill is provided. Methods for the detection of cellular hypoxia, both in vivo and in vitro, are additionally provided.
-80. (canceled)
A compound of Formula IV or VI:
A method of detecting hypoxic cells in vitro or in vivo in a group of cells, the method comprising:
Dependencies are inferred from the claim text.